Biote (BTMD) Capital Expenditures (2021 - 2026)

Biote's Capital Expenditures history runs 6 years deep, the most recent figure standing at $806000.0 for Q1 2026.

• In Q1 2026, Capital Expenditures fell 50.55% year-over-year to $806000.0; the TTM figure through Mar 2026 stood at $4.2 million (up 188.64% YoY), while the FY2025 annual figure was $5.0 million, up 853.42% from the prior year.
• Capital Expenditures was $806000.0 for Q1 2026 at Biote, down from $1.1 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.8 million in Q4 2023 to a low of -$590000.0 in Q4 2024.
• Historically, Capital Expenditures has averaged $564625.0 across 5 years, with a median of $440500.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures surged 36620.0% in 2023, then tumbled 1100.0% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $5000.0 in 2022, then soared by 36620.0% to $1.8 million in 2023, then tumbled by 132.14% to -$590000.0 in 2024, then jumped by 282.54% to $1.1 million in 2025, then retreated by 25.16% to $806000.0 in 2026.
• The last three Capital Expenditures figures came in at $806000.0 (Q1 2026), $1.1 million (Q4 2025), and $499000.0 (Q3 2025), per Business Quant data.